Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Initial inhaler choice in COPD: real-world evidence

Thomas Jones
Breathe 2019 15: 350-352; DOI: 10.1183/20734735.0256-2019
Thomas Jones
Dept of Respiratory Medicine, Portsmouth Hospitals NHS Trust, and Faculty of Science, University of Portsmouth, Portsmouth, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Jones
  • For correspondence: Tom.jones@doctors.org.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 15 no. 4 350-352
DOI 
https://doi.org/10.1183/20734735.0256-2019

Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Published online December 1, 2019.

Copyright & Usage 
Copyright ©ERS 2019 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Thomas Jones⇑
  1. Dept of Respiratory Medicine, Portsmouth Hospitals NHS Trust, and Faculty of Science, University of Portsmouth, Portsmouth, UK
  1. E-mail: Tom.jones{at}doctors.org.uk
View Full Text

Article usage

Article usage: November 2019 to May 2023

AbstractFullPdf
Nov 2019022
Dec 20193429128
Jan 2020210133
Feb 202028541
Mar 2020412124
Apr 202017810
May 202014814
Jun 202014823
Jul 202004618
Aug 202013913
Sep 202056623
Oct 202011428
Nov 202043510
Dec 202055511
Jan 202115312
Feb 20210348
Mar 202105117
Apr 20210316
May 202133911
Jun 20210208
Jul 20212179
Aug 20210247
Sep 20211244
Oct 202103828
Nov 202112518
Dec 20211369
Jan 20220233
Feb 20220186
Mar 20222367
Apr 202232312
May 202202410
Jun 20223235
Jul 20220215
Aug 20222255
Sep 202211710
Oct 20223217
Nov 20222325
Dec 202212516
Jan 202311713
Feb 20235216
Mar 20230388
Apr 20232541
May 20230269

Altmetrics

PreviousNext
Back to top
Vol 15 Issue 4 Table of Contents
Breathe: 15 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Initial inhaler choice in COPD: real-world evidence
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Initial inhaler choice in COPD: real-world evidence
Thomas Jones
Breathe Dec 2019, 15 (4) 350-352; DOI: 10.1183/20734735.0256-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Initial inhaler choice in COPD: real-world evidence
Thomas Jones
Breathe Dec 2019, 15 (4) 350-352; DOI: 10.1183/20734735.0256-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Context
    • Methods
    • Main results
    • Commentary
    • Implications for practice
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Journal club

  • Impact of triple therapy on mortality in COPD
  • CPAP for secondary cardiovascular prevention in OSA patients
  • Maternal vaccination during pregnancy against infant respiratory viruses
Show more Journal club

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society